Ischemia: Clinical Trials

233 trials for Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

233 completed. 233 Phase 3, 32 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3233Completed 233
Phase 232Completed 32

Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia

Trials (filtered) newest first · largest first

All 233 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TADCLOT- a Double Blind Randomized Controlled Trial
Ticagrelor 90 MG, Clopidogrel - Stent Thrombosis, Myocardial Infarction, Acute
Phase 3CompletedNational Institute of Cardiovascular Diseases, Pakistan22002024-02-192025-07-10
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Tenecteplase, direct EVT - Ischemic Stroke, Acute, Thrombolysis
Phase 3CompletedBeijing Tiantan Hospital3912024-01-252025-11-26
Evaluation in STEMI Patients Using FDY-5301
FDY-5301, Placebo - Acute Myocardial Infarction, STEMI
Phase 3CompletedFaraday Pharmaceuticals, Inc.23512022-05-022025-09-12
Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock
Oxygen gas - Cardiogenic Shock, Extracorporeal Membrane Oxygenation
Phase 3CompletedCentre Hospitalier Universitaire de Besancon602022-01-092024-12-30
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
Rivaroxaban 2.5 MG [Xarelto], DAPT strategy - Myocardial Infarction, Acute, Left Ventricular Thrombus
Phase 3CompletedAssistance Publique - Hôpitaux de Paris5602021-10-102024-07-10
Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients
Dapagliflozin 10mg, Glucose Tab - Anterior MI
Phase 2 / Phase 3CompletedOmar Younis1002021-10-012024-11-19
MSCs for Prevention of MI-induced HF
Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs), Conventional Treatment - Myocardial Infarction, Acute, Myocardial Infarction First
Phase 3CompletedShiraz University of Medical Sciences4202021-09-152024-11-04
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
GNR-060, Metalyse - ST Elevation Myocardial Infarction
Phase 3CompletedAO GENERIUM2442021-09-032026-09-21
LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients
Levosimendan, Placebo of Levosimendan - Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication
Phase 3CompletedAssistance Publique - Hôpitaux de Paris2062021-08-272025-03-21
Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography
Dapagliflozin 10Mg Tab, Placebo - Diabete Type 2, Unstable Angina
Phase 3CompletedHilda Elizabeth Macías Cervantes542021-06-212023-08-21
Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
Ticagrelor 90mg, Ticagrelor 60 mg - Acute Coronary Syndrome, STEMI
Phase 3CompletedFederico II University502021-04-012022-07-07
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
Dapagliflozin, Placebo - Acute Myocardial Infarction, Heart Failure
Phase 3CompletedAstraZeneca40172020-12-222025-03-07
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
Empagliflozin, Placebo - Myocardial Infarction
Phase 3CompletedBoehringer Ingelheim65222020-12-162025-01-07
Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
Rivaroxaban 15 MG, Warfarin - Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction
Phase 3CompletedRajaie Cardiovascular Medical and Research Center502020-07-302023-04-07
The Effect of Colchicine on Inflammation in ACS Patients
Colchicine Tablets - Acute Coronary Syndrome, STEMI
Phase 3CompletedAin Shams University882020-02-012023-09-26
Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD
TQJ230, Placebo - Cardiovascular Disease and Lipoprotein(a)
Phase 3CompletedNovartis Pharmaceuticals83232019-12-122026-08-28
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard treatment - Cerebral Ischemia, Cerebral Infarction
Phase 3CompletedPharmazz, Inc.1582019-11-102023-10-18
Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia
Mexidol, Placebo - Chronic Cerebral Ischemia
Phase 3CompletedPharmasoft3182019-11-052025-10-06
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
NL003, Normal Saline - Arterial Occlusive Disease, Ischemia
Phase 3CompletedBeijing Northland Biotech. Co., Ltd.2422019-08-282024-09-20
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)
NL003, Normal Saline - Arterial Occlusive Disease, Ischemia
Phase 3CompletedBeijing Northland Biotech. Co., Ltd.3022019-08-022024-09-19

Showing 20 of 233. Sign in to see all of them.

Narrower conditions

Myocardial Infarction (150)  ·  Cardiovascular Diseases (44)  ·  ST Elevation Myocardial Infarction (41)  ·  Heart Diseases (40)  ·  Myocardial Ischemia (38)  ·  Stroke (36)  ·  Coronary Disease (27)  ·  Acute Coronary Syndrome (26)  ·  Coronary Artery Disease (23)  ·  Heart Failure (19)  ·  Angina, Unstable (18)  ·  Cerebral Infarction (12)  ·  Chronic Limb-Threatening Ischemia (10)  ·  Angina Pectoris (9)

Broader conditions

Pathological Conditions, Signs and Symptoms (233)  ·  Pathologic Processes (232)  ·  Vascular Diseases (225)  ·  Necrosis (203)  ·  Infarction (200)  ·  Cardiovascular Diseases (187)  ·  Heart Diseases (155)  ·  Myocardial Ischemia (155)  ·  Nervous System Diseases (49)  ·  Brain Diseases (47)  ·  Central Nervous System Diseases (47)  ·  Cerebrovascular Disorders (43)  ·  Signs and Symptoms (42)  ·  Arteriosclerosis (39)

Interventions

Clopidogrel (15)  ·  Aspirin (11)  ·  Ticagrelor (10)  ·  Enoxaparin (8)  ·  Prasugrel Hydrochloride (7)  ·  Tissue Plasminogen Activator (7)  ·  Heparin (6)  ·  Tenecteplase (6)  ·  Rivaroxaban (5)  ·  Standard of Care (5)  ·  Percutaneous Coronary Intervention (4)  ·  Rosuvastatin Calcium (4)  ·  Saline Solution (4)  ·  bivalirudin (4)  ·  Abciximab (3)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (20)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  Boehringer Ingelheim (6)  ·  AstraZeneca (5)  ·  GlaxoSmithKline (4)  ·  Sanofi (4)  ·  Brigham and Women's Hospital (3)  ·  Novartis Pharmaceuticals (3)  ·  Population Health Research Institute (3)  ·  Rutgers, The State University of New Jersey (3)  ·  Stiftung Institut fuer Herzinfarktforschung (3)  ·  Tanabe Pharma Corporation (3)  ·  The Medicines Company (3)  ·  University of Leipzig (3)  ·  University of Washington (3)

Countries

United States (65)  ·  Canada (46)  ·  Germany (42)  ·  France (41)  ·  Italy (29)  ·  Poland (28)  ·  Spain (28)  ·  United Kingdom (27)  ·  Belgium (26)  ·  Czechia (24)  ·  Netherlands (23)  ·  Sweden (23)  ·  Hungary (22)  ·  Australia (21)  ·  China (21)

Top investigators

Ali Eskandari, MD (2)  ·  Allan Barker (2)  ·  David Richardson (2)  ·  Eugene Braunwald (2)  ·  Gary Wilner (2)  ·  Hamid Gourabi, PhD (2)  ·  Hossein Baharvand, PhD (2)  ·  Hossein Vakili, M.D. (2)  ·  J. McNamara (2)  ·  James Schoenberger (2)  ·  James Willerson (2)  ·  Jeffrey L Carson, MD (2)

Results publications

PMID 35224730, PMID 34932836, PMID 41114449, PMID 19131498, PMID 20189026, PMID 23174632, PMID 24561145, PMID 25572507, PMID 26198286, PMID 27160944, PMID 27165710, PMID 27287251, PMID 11239408, PMID 12324494, PMID 12460865, PMID 12507972, PMID 14699020, PMID 15077099, PMID 15238590, PMID 15321804, PMID 15480537, PMID 15498829, PMID 15534844, PMID 15910853, PMID 15949912, PMID 16183441, PMID 16304073, PMID 16537663, PMID 16537665, PMID 16537725, PMID 16543037, PMID 16613998, PMID 16651474, PMID 16750696, PMID 16757723, PMID 16763187, PMID 16801465, PMID 16864722, PMID 16978651, PMID 16990384, PMID 17010793, PMID 17015064, PMID 17098754, PMID 17105759, PMID 17124018, PMID 17126719, PMID 17161253, PMID 17172279, PMID 17299194, PMID 17310025

NIH funding

2019 (3), 2009 (2), 2016 (2), 1RC2HL101458-01 (1), 2005 (1), 2015 (1), 2018 (1), M01RR000048 (1), M01RR000645 (1), M01RR007122 (1), P20RR011104 (1), R01AT009273 (1), R01DC008796 (1), R01HL028843 (1), R01HL030300 (1)